13th Feb 2009 17:27
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned persons on 13 February 2009 of an increase in the notional allocation of Ordinary Share ADRs on 12 February 2009 at a price of $35.33 per ADR:-
|
Dr M M Slaoui |
5 |
|
Mrs C Bruck Slaoui |
1 |
|
Mr E J Gray |
23 |
|
Mr W C Louv |
11 |
|
Dr D Pulman |
24 |
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
13 February 2009
Related Shares:
Glaxosmithkline